Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A Hebert

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathyAnwarul Kabir, Tibor Nadasdy, Gyongyi Nadasdy, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2017
The Urine Preservative Acetic Acid Degrades Urine Protein: Implications for Urine Biorepositories and the AASK Cohort StudySalem Almaani, Lee A Hebert, Brad H Rovin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2011
A modest proposal for improving the accuracy of creatinine-based GFR-estimating equationsPaul L Hebert, Uday S Nori, Udayan Y Bhatt, et al.
American Journal of Nephrology|September 21, 2013
Differential diagnosis of glomerular disease: a systematic and inclusive approachLee A Hebert, Samir Parikh, Jason Prosek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 2, 2003
High urine volume and low urine osmolality are risk factors for faster progression of renal diseaseLee A Hebert, Tom Greene, Andrew Levey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 5, 2005
Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progressionLee A Hebert, Brad H Rovin, Anil K Agarwal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney diseaseUlrich O Wenzel, Lee A Hebert, Rolf A K Stahl, et al.
Kidney & Blood Pressure Research|July 21, 2007
Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapyNabil Haddad, James Rajan, Haikady N Nagaraja, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapyTodd E Pesavento, William H Bay, Garima Agarwal, et al.
Clinical Nephrology|February 6, 2013
Unexplained severe acute kidney injury with rapid recovery of kidney function 11 months later after the start of high-dose steroid therapyDan Roncone, Brad Rovin, Ronald Falk, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2004
An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathyAnwarul Kabir, Tibor Nadasdy, Gyongyi Nadasdy, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2017
The Urine Preservative Acetic Acid Degrades Urine Protein: Implications for Urine Biorepositories and the AASK Cohort StudySalem Almaani, Lee A Hebert, Brad H Rovin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2011
A modest proposal for improving the accuracy of creatinine-based GFR-estimating equationsPaul L Hebert, Uday S Nori, Udayan Y Bhatt, et al.
American Journal of Nephrology|September 21, 2013
Differential diagnosis of glomerular disease: a systematic and inclusive approachLee A Hebert, Samir Parikh, Jason Prosek, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 2, 2003
High urine volume and low urine osmolality are risk factors for faster progression of renal diseaseLee A Hebert, Tom Greene, Andrew Levey, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 5, 2005
Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progressionLee A Hebert, Brad H Rovin, Anil K Agarwal, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney diseaseUlrich O Wenzel, Lee A Hebert, Rolf A K Stahl, et al.
Kidney & Blood Pressure Research|July 21, 2007
Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapyNabil Haddad, James Rajan, Haikady N Nagaraja, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 26, 2004
Mycophenolate therapy in frequently relapsing minimal change disease that has failed cyclophosphamide therapyTodd E Pesavento, William H Bay, Garima Agarwal, et al.
Clinical Nephrology|February 6, 2013
Unexplained severe acute kidney injury with rapid recovery of kidney function 11 months later after the start of high-dose steroid therapyDan Roncone, Brad Rovin, Ronald Falk, et al.
Pageof 8